ArticleOncoTargets and therapy2020

RTKN2 is Associated with Unfavorable Prognosis and Promotes Progression in Non-Small-Cell Lung Cancer.

Lupeng Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.